MENU
BGM
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

BGM stock forecast, quote, news & analysis

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
BGM
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for BGM with price predictions
Oct 21, 2026

BGM's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for BGM moved out of overbought territory on October 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 instances where the indicator moved out of the overbought zone. In 15 of the 16 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BGM as a result. In 112 of 113 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BGM turned negative on October 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 50 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BGM moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for BGM crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +14.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BGM advanced for three days, in 157 of 182 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

BGM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Industry description

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
BGM's RSI Oscillator leaves overbought zone